The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes

Bernard Pereira(University of Cambridge), Carlos Caldas(University of Cambridge), Gulisa Turashvili(Harvard University), Linda Jones(University of Cambridge), Dana W.Y. Tsui(Memorial Sloan Kettering Cancer Center), Helen Northen(Illumina (United Kingdom)), Suet‐Feung Chin(University of Cambridge), Arnie Purushotham(King's College London), Helen Bardwell(University of Cambridge), Sohrab P. Shah(Memorial Sloan Kettering Cancer Center), Stephen‐John Sammut(Cambridge University Hospitals NHS Foundation Trust), Leigh C. Murphy(CancerCare Manitoba), Nitzan Rosenfeld(Queen Mary University of London), Elena Provenzano(University of Cambridge), Abhik Mukherjee(University of Nottingham), Samuel Aparício(BC Cancer Agency), Ian O. Ellis(University of Nottingham), Helena Earl(University of Cambridge), Paul D.P. Pharoah(Cedars-Sinai Medical Center), Sarah‐Jane Dawson(The University of Melbourne), Andrew R. Green(Nottingham Biomedical Research Centre), Bin Liu(College of Marin), Roslin Russell(University of Cambridge), Mark T. Ross(Illumina (United Kingdom)), Anne‐Lise Børresen‐Dale(Oslo University Hospital), Michelle Pugh(Cancer Research UK), David Bentley(Illumina (United Kingdom)), Steve McKinney(BC Cancer Agency), Hans-Kristian Moen Vollan(Oslo University Hospital), Sarah E. Pinder(St Thomas' Hospital), Arusha Oloumi(École Nationale Supérieure de Chimie de Montpellier), Oscar M. Rueda(University of Cambridge), John F. Peden(Centre for Human Genetics), Jean Abraham(Cancer Research UK)
Nature Communications
May 10, 2016
Cited by 1,816


Related Papers